Literature DB >> 12657103

Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty.

Masayuki Furuhata1, Masatsugu Iwamura, Shiro Baba, Matsuhisa Inoue.   

Abstract

The present report concerns a 38-year-old man, who had been treated with pyeloplasty and lithotomy for the improvement of urinary excretion and resolution of a kidney stone. The patient developed a biofilm infection involving Pseudomonas aeruginosa and Staphylococcus epidermidis, and had been suffering from recurrent acute pyelonephritis for one year. Combination therapy with clarithromycin (CAM) and imipenem/cilastatin (IMP/CS) consisted of administration of CAM at a dose of 400 mg/day for 1 week, followed by 500 mg/day of IMP by intravenous infusion combined with CAM (400 mg/day) for 5 days. This therapy produced an immediate antimicrobial effect and no further signs of pyuria have been seen during one year of follow-up in this patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657103     DOI: 10.1046/j.0919-8172.2003.00598.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  5 in total

Review 1.  Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence.

Authors:  Matthew E Falagas; Anastasios M Kapaskelis; Vasilios D Kouranos; Ourania K Kakisi; Zoe Athanassa; Drosos E Karageorgopoulos
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

2.  Activity of imipenem against Klebsiella pneumoniae biofilms in vitro and in vivo.

Authors:  Ping Chen; Akhil K Seth; Johnathan J Abercrombie; Thomas A Mustoe; Kai P Leung
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

3.  In Vitro Antibacterial, Antifungal, Antibiofilm, Antioxidant, and Anticancer Properties of Isosteviol Isolated from Endangered Medicinal Plant Pittosporum tetraspermum.

Authors:  Naif Abdullah Al-Dhabi; Mariadhas Valan Arasu; Thankappan Sarasam Rejiniemon
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-26       Impact factor: 2.629

4.  In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions.

Authors:  Diego Parra; Alejandro Peña-Monje; Nieves María Coronado-Álvarez; José Hernández-Quero; Jorge Parra-Ruiz
Journal:  BMC Microbiol       Date:  2015-10-30       Impact factor: 3.605

5.  A screening for antimicrobial activities of Caribbean herbal remedies.

Authors:  Claribel Luciano-Montalvo; Isabelle Boulogne; Jannette Gavillán-Suárez
Journal:  BMC Complement Altern Med       Date:  2013-06-04       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.